Dr. Zvi Gabbay heads our Capital Markets department. Zvi possesses extensive experience in Israel and in the United States, representing corporations and individuals in various aspects of their operations, mainly in the areas of financial regulation, securities, capital markets and international litigation.
Over more than 18 years of practice in the fields of financial regulations and enforcement, Zvi attained an esteemed reputation for representing clients before the regulatory authorities on matters pertaining to securities laws and financial regulation, for providing ongoing legal advice to private clients and to leading corporations in relation to their capital market and corporate governance needs, as well as for representing clients before various enforcement agencies during administrative inquiries and investigations.
Zvi specializes in securities law and in advising public companies, banks, investment houses and financial entities in relation to their activities in the global arena.
Zvi also represents clients before the regulatory authorities on matters pertaining to securities laws and financial regulation, and provides ongoing legal advice to individuals and leading corporations in relation to their capital market and corporate governance needs. Zvi also represents clients in securities-related enforcement proceedings, including criminal and administrative inquiries and investigations.
Zvi’s vast experience includes roles as Head of Enforcement and member of the management of the Israel Securities Authority, as a lawyer in the New York office of Skadden, Arps, Slate, Meagher & Flom, as a prosecutor in the Tel-Aviv District Attorney’s office, as a partner in a major law firm in Israel and as a founding partner of a boutique capital market firm.
JSD, Columbia University, New York, 2006
LL.M, summa cum laude, Columbia University, New York, 2004
LL.M, magna cum laude, in commercial law, Bar-Ilan University, Ramat-Gan, 2002
LL.B, Hebrew University, Jerusalem, 1999
Member of Israel Bar Association since 1999
Member of New York Bar Association since 2005
News and updates - Zvi Gabbay:
The SEC Charges Two Israeli Residents with Insider Trading – Opinion Article
Dr. Zvi Gabbay, Head of the Capital Markets Department at Barnea & Co., in an opinion article following the decision of the US Securities and Exchange Commission (SEC) to file a civil suit in a federal court against two Israeli residents who traded in Mobileye's stock and options before and after the merger announcement with Intel Corp. Dr. Gabbay commented that the case which the SEC has formulated against the two Israelis on suspicion of using insider trading information is in the meantime very circumstantial.
The Hong Kong Stock Exchange has formally approved Israel as an ‘Acceptable Jurisdiction’.
Dr. Zvi Gabbay, Head of the Capital Markets Department at Barnea & Co. was interviewed by The Marker following the approval of the Hong Kong Stock Exchange (‘HKSE’) Israel as an ‘Acceptable Jurisdiction’. Zvi commented that the HKSE’s approval is currently limited to foreign listed Israeli public companies and Israeli private companies seeking a listing on the HKSE and it could also translate into cost savings for such companies.
Medigus Ltd. Completed a Nasdaq IPO
Barnea & Co. represented a group of US underwriters, led by H.C. Wainwright & Co., LLC, in the process of submission of Medigus Ltd. of a prospectus for the Nasdaq listing. Medigus raised USD 7.5 million and will be traded on Nasdaq in parallel with its listing on the Tel Aviv Stock Exchange. Medigus Ltd is an Israel-based company active in the medical sector. It specializes in developing endoscopic procedures and devices.